Google Alert - hepatitis c

[Guest guest]

News

9 new results for hepatitis c

First Vaccine for Viral Hepatitis C Could Become a RealityPR Newswire (press release) C et al. A therapeutic vaccine for HCV based on novel, rare, adenoviral vectors. Abstract Presented at The International Liver Congress TM 2011 2. E. Phase I trials of a highly immunogenic and durable T-cell vaccine for Hepatitis C virus ...See all stories on this topic »

Sustained viral response achieved in 83% of hepatitis C infected patients with ...Montreal GazetteC. Yong, et al.) Preclinical characterization of the hepatitis C virus NS5B polymerase non-nucleoside inhibitor BILB 1941 (Poster 1215. G. Kukolj et. al.) Posters are presented on Saturday, 2 April, 2011, 09:00h - 18:00h. HCV is an infectious disease ...See all stories on this topic »

Drug cocktail Offers New Hope For Hepatitis C PatientsIvanhoe(Ivanhoe Newswire) -- People who suffer from hepatitis C may be in luck—according to researchers at Henry Ford Hospital, a new three-drug cocktail eliminates the virus more effectively than the current two-drug treatment. At least 3.2 million ...See all stories on this topic »

Medivir: Week 24 Interim Results From TMC435 Hepatitis C Phase 2b ASPIRE Study ...PR Newswire (press release)Treatment experienced patients are known to be the most difficult to treat hepatitis C patient group. TMC435 is a potent, once-daily, oral hepatitis C virus protease inhibitor which recently entered clinical phase 3 studies. The study enrolled patients

....See all stories on this topic »

First Vaccine for Viral Hepatitis C Could Become a RealityHealthNewsDigest.comAbstract presented at the International Liver [2] E. Phase I trials of a highly immunogenic and durable T-cell vaccine for Hepatitis C virus based on novel, rare, adenoviral vectors. Abstract presented at the International Liver Congress ...See all stories on this topic »

Biolex Announces Hepatitis Trial DataDrug Discovery & DevelopmentBiolex Therapeutics, Inc. announced that final 72-week results from its SELECT-2 Phase 2b trial of Locteron for the treatment of hepatitis C were presented at the 46th Annual Meeting of the European Association for the Study of the Liver (EASL) in ...See all stories on this topic »

Cirrhosis and HCC Have Risen Dramatically in Hepatitis C PatientsInternal Medicine News Digital NetworkThe burden of cirrhosis, hepatic decompensation, and hepatocellular carcinoma has risen dramatically during the past decade among patients with chronic hepatitis C virus infection, Dr. Fasiha Kanwal and her colleagues reported in the April issue of ...See all stories on this topic »

'Victrelis'™ (Boceprevir) In Combination Therapy Significantly Increased Cure ...Medical News Today (press release)MSD announced that final results from the two pivotal Phase III studies of 'Victrelis'™ (boceprevir), its investigational oral hepatitis C protease inhibitor, will be published in the March 31st edition of The New England Journal of Medicine (NEJM). ...See all stories on this topic »

Novartis first-in-class antiviral DEB025 achieved sustained viral response in ...IEWY NewsBasel, – Novartis announced today that a Phase II study with the first-in-class antiviral DEB025 (alisporivir) met its primary endpoint for achieving viral cure (24 weeks after stopping treatment) in 76% of patients with chronic hepatitis C[1]. ...See all stories on this topic »